Cannabis use in pregnancy and breastfeeding: The pharmacist’s role
Authors:
- 8 January 2020
- journal article
- review article
- Published by University of Toronto Press Inc. (UTPress) in Canadian Pharmacists Journal / Revue des Pharmaciens du Canada
- Vol. 153 (2) , 95-100
Abstract
The recent legalization of cannabis use in Canada requires pharmacists to be able to support their patients with accurate knowledge of its known risks and benefits. Certain populations, such as pregnant and breastfeeding women and their developing children, may be at higher risk than other populations. The authors independently searched the literature for clinical reports or reviews of the literature regarding the safety of cannabis use in pregnancy and breastfeeding using search terms such as cannabis, marijuana, pregnancy and breastfeeding. This review combines the relevant pharmacological, pharmacokinetic and clinical evidence for the effects of cannabis in this special patient population. The literature demonstrates that some of the constituents of cannabis can reach children in utero and through breastmilk. Given that Δ⁹-tetrahydrocannabinol can be present in breastmilk as quickly as 1 hour after consumption and last up to 6 days, it may not be possible to use cannabis and avoid infant exposure. There is evidence that this exposure may result in cognitive, social and motor defects. Some of these effects may be long term, lasting years. The pharmacist must be able to educate and screen patients regarding marijuana use in pregnancy and breastfeeding, with the ultimate aim of harm reduction.Keywords
This publication has 31 references indexed in Scilit:
- Cannabis Use During the Perinatal Period in a State With Legalized Recreational and Medical Marijuana: The Association Between Maternal Characteristics, Breastfeeding Patterns, and Neonatal OutcomesThe Journal of Pediatrics, 2018
- Transfer of Inhaled Cannabis Into Human Breast MilkObstetrics & Gynecology, 2018
- Trends in perception of risk of regular marijuana use among US pregnant and nonpregnant reproductive-aged womenAmerican Journal of Obstetrics and Gynecology, 2017
- Marijuana use and its effects in pregnancyAmerican Journal of Obstetrics and Gynecology, 2016
- Prenatal exposure to cannabis and maternal and child health outcomes: a systematic review and meta-analysisBMJ Open, 2016
- Risk Factors for Preterm Birth in an International Prospective Cohort of Nulliparous WomenPLOS ONE, 2012
- Intrauterine Cannabis Exposure Affects Fetal Growth Trajectories: The Generation R StudyJournal of the American Academy of Child & Adolescent Psychiatry, 2009
- Human Cannabinoid PharmacokineticsChemistry & Biodiversity, 2007
- 12- and 24-month neurobehavioural follow-up of children prenatally exposed to marihuana, cigarettes and alcoholNeurotoxicology and Teratology, 1988
- Presence of Δ9-Tetrahydrocannabinol in Human MilkNew England Journal of Medicine, 1982